Kerecis and Recell in Patients with Necrotizing Fasciitis: Report of Our First Experience in Three Patients
Abstract
Necrotizing soft tissue infections (NSTI) are serious infections that are typically treated with aggressive debridements. Coverage of those extensive full-thickness integumentary defects requires complex reconstructions of both the dermal and epidermal layers with the goal of achieving close to normal pliability. A key determinant factor in the development of scar tissue is the time to create a graftable surface and curtail inflammatory reactions. A second limiting factor is the extent of donor skin needed for coverage. Kerecis, a fish skin-derived regenerative tissue matrix, is a novel product that has shown good promise in the rapid generation of a graftable, pliable dermal matrix in burn patients. Additionally, it decreases the inflammatory reaction through its Omega-3 polyunsaturated fatty acids content. The ReCell system produces a regenerative skin cell suspension of a patient's own skin, with a reduction in the size of the skin graft needed for coverage. The combined use of Kerecis and ReCell provides a promising reconstructive approach that may speed up definitive coverage while reducing donor-site morbidity and pain.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.